Apimeds Pharmaceuticals US, Inc. (APUS) › EPS (Diluted)Apimeds Pharmaceuticals US, Inc. (APUS) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $-0.172024: $-0.182025: $-0.55$-0.552023EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.55-205.6%2024$-0.18-5.9%2023$-0.17—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share